Guizhou Jingfeng Pharmaceutical

Guizhou Jingfeng Pharmaceutical is a core subsidiary of the Hunan Jingfeng Pharmaceutical Group, a publicly traded Chinese pharmaceutical company specializing in injectable medications. The company focuses on several key therapeutic areas, including cardiovascular health, orthopedics, and ophthalmology, with a portfolio that blends chemical drugs and modernized Traditional Chinese Medicine (TCM). Its flagship products include Sodium Hyaluronate Injection for joint and eye health, as well as TCM injections like Shenmai and Dengzhan Xixin. Guizhou Jingfeng operates multiple GMP-certified production lines and maintains a strong presence in the domestic Chinese market. Despite recent financial restructuring at the group level, the Guizhou entity remains a vital operational unit for the company's commercial strategy.